Karl Mechtler

Karl Mechtler has led the Protein Chemistry Facility at the Research Institute of Molecular Pathology (IMP) in Vienna, Austria since 1989. As Head of Facility, he directs research operations focused on advanced mass spectrometry applications in molecular and cellular biology. His facility provides critical infrastructure for proteomic analysis while conducting innovative research in protein chemistry methodologies.

Mechtler's core research interests center on:

• Developing high-sensitivity mass spectrometry techniques
• Advancing crosslinking approaches for structural proteomics
• Optimizing single-cell proteomic workflows
• Analyzing posttranslational modifications
• Creating bioinformatic solutions for proteome analysis
• Improving quantitative accuracy in multiplexed proteomics

Recent publications demonstrate his lab's focus on pushing technical boundaries in proteomics, with 2024-2025 research featuring innovations in Orbitrap Astral applications, FAIMS technology for peptide coverage, AI-driven data analysis, and novel crosslinking strategies. These methodological advances enable new biological insights into areas ranging from chromatin dynamics to neurological disorders.

His research is supported by active grants including:

• 'Delineating the crossover control networks in plants' (German Research Foundation, ongoing since 2014)
• 'SFB F3402-B03: Chromosome dynamics' (Austrian Science Fund FWF)

Mechtler leads the Protein Chemistry Facility at IMP, which maintains an active web presence detailing its research focus and capabilities. The lab specializes in developing cutting-edge mass spectrometry solutions for challenging biological questions.